Your browser doesn't support javascript.
loading
Patient Outcomes by Ventricular Systolic and Diastolic Function.
Levene, Jacqueline; Voigt, Andrew; Thoma, Floyd; Mulukutla, Suresh; Bhonsale, Aditya; Kancharla, Krishna; Shalaby, Alaa; Estes, N A Mark; Jain, Sandeep; Saba, Samir.
Afiliación
  • Levene J; Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.
  • Voigt A; Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.
  • Thoma F; Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.
  • Mulukutla S; Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.
  • Bhonsale A; Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.
  • Kancharla K; Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.
  • Shalaby A; Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.
  • Estes NAM; Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.
  • Jain S; Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.
  • Saba S; Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.
J Am Heart Assoc ; 13(4): e033211, 2024 Feb 20.
Article en En | MEDLINE | ID: mdl-38353214
ABSTRACT

BACKGROUND:

Left ventricular dysfunction is characterized by systolic and diastolic parameters, leading to heart failure (HF) with reduced or preserved ejection fraction (EF), respectively. The goal of this study is to examine the impact of left ventricular systolic and diastolic dysfunction (DD) on patient outcomes. METHODS AND

RESULTS:

Two cohorts were used in this

analysis:

Cohort A included 136 455 patients with EF ≥50%, stratified by the presence and grade of DD. Cohort B included 16 850 patients with EF <50%, stratified by EF quartiles. Patients were followed to the end points of all-cause death and cardiovascular, HF, or cardiac arrest hospitalizations. Over a median follow-up of 3.42 years, 23 946 (16%) patients died and 31 113 (20%), 13 305 (9%), and 1269 (1%) were hospitalized for cardiovascular, HF, or cardiac arrest causes, respectively. With adjustment for comorbidities, the risk of all-cause mortality and of cardiovascular and HF hospitalizations increased steadily with increasing grade of DD in patients with normal EF, and even more so in patients with worsening EF. The risk of hospitalization for cardiac arrest in patients with grade III DD, however, was comparable to that of patients with EF <25% (hazard ratio, 1.00 [95% CI, 0.98-1.01]) and worse than that of patients in better EF quartiles.

CONCLUSIONS:

Although systolic dysfunction is associated with a greater risk of overall death and HF hospitalizations than DD, the risk of cardiac arrest in patients with grade II and III DD is comparable to that of patients with moderate and severe systolic dysfunction, respectively. Future studies are needed to examine treatment strategies than can improve these outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_other_circulatory_diseases Asunto principal: Paro Cardíaco / Insuficiencia Cardíaca / Cardiomiopatías Límite: Humans Idioma: En Revista: J Am Heart Assoc Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_other_circulatory_diseases Asunto principal: Paro Cardíaco / Insuficiencia Cardíaca / Cardiomiopatías Límite: Humans Idioma: En Revista: J Am Heart Assoc Año: 2024 Tipo del documento: Article
...